Latest market price
14.65
+0.72+5.17%
OverviewShort InterestFilings
JBIOQT27Jade Biosciences, Inc.·NASDAQ
14.65+5.17%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 28, 2026SC 13GBeneficial ownership statement (passive)
Oct 27, 2026SC 13GBeneficial ownership statement (passive)
Jun 03, 2026424B5Prospectus
Jun 01, 20268-KCurrent report
May 15, 2026424B3Prospectus
May 15, 2026EFFECTNotice of effectiveness
May 15, 2026EFFECTNotice of effectiveness
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 20268-KCurrent report
May 07, 2026424B3Prospectus
May 07, 2026S-8Registration of employee benefit securities
May 07, 2026S-3Shelf registration statement
May 07, 202610-QQuarterly report
May 07, 2026424B3Prospectus
May 07, 2026S-3Shelf registration statement
Apr 28, 2026DEF 14ADefinitive proxy statement
Apr 28, 2026ARSAnnual report to shareholders
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 22, 20268-KCurrent report
Apr 17, 2026PRE 14APreliminary proxy statement
Apr 02, 20268-KCurrent report
Mar 06, 2026424B3Prospectus
Mar 06, 20268-KCurrent report
Mar 06, 202610-KAnnual report
#1 / 25 of 476
Page
▼
/ 20